BRIEF-Biovaxys And Bioelpida Sign Term Sheet For Clinical Grade Bvx-0918A Bio-Production
- ByReuters-
Feb 18 (Reuters) - Biovaxys Technology Corp BIOV.CD :* BIOVAXYS AND BIOELPIDA SIGN TERM SHEET FOR CLINICAL GRADE BVX-0918A BIO-PRODUCTION
Feb 18 (Reuters) - Biovaxys Technology Corp BIOV.CD :* BIOVAXYS AND BIOELPIDA SIGN TERM SHEET FOR CLINICAL GRADE BVX-0918A BIO-PRODUCTION
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Strong Sell | Sell | Strong Buy |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 26.82 | 27.67 | 25.80 | -0.47 | -1.72% | 7.15M | Toronto | |||
| 13.94 | 14.10 | 13.84 | -0.01 | -0.07% | 337.71K | Toronto | |||
| 0.01 | 0.00 | 0.00 | 0.000 | 0.00% | 1.70M | CSE | |||
| 9.96 | 9.98 | 9.32 | +0.47 | +4.95% | 13.78M | Toronto | |||
| 2.23 | 2.51 | 2.10 | -0.28 | -11.16% | 639.81K | Toronto | |||
| 1.00 | 1.04 | 0.00 | -0.02 | -1.96% | 560.90K | Toronto | |||
| 0.25 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00K | TSXV | |||
| 50.07 | 50.32 | 49.51 | +0.36 | +0.72% | 3.73M | Toronto | |||
| 21.12 | 23.25 | 20.43 | -1.890 | -8.21% | 6.85M | Toronto | |||
| 18.65 | 19.33 | 18.46 | -0.52 | -2.71% | 961.37K | Toronto | |||
| 33.75 | 33.94 | 33.35 | -0.26 | -0.76% | 422.29K | Toronto | |||
| 0.20 | 0.00 | 0.00 | -0.0550 | -21.57% | 2.14M | TSXV | |||
| 9.25 | 10.89 | 8.66 | -1.340 | -12.65% | 312.58K | NEO | |||
| 0.46 | 0.00 | 0.00 | +0.01 | +1.10% | 7.47M | Toronto | |||
| 0.015 | 0.00 | 0.00 | -0.0050 | -25.00% | 667.00K | TSXV |
Biovaxys Technology Corp., formerly Lions Bay Mining Corp., is a Canada-based clinical-stage immunotherapeutics company. The Company develops vaccine platforms for SARS-CoV-2 and various cancers.